1102683

Marshall Freeman, M.D. — FEI 3015468250

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 10, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Greensboro, NC (United States)

Additional Details

Clinical Investigator (CI)